The new vaccine is being developed by the Oxford Vaccine Group (OVG) using the ChAdOx1 platform, similar to the COVID-19 vaccine made by AstraZeneca. The vaccine aims to counter the Bundibugyo strain of Ebola, a rare species, which has resulted in a massive outbreak with over 200 confirmed deaths. The DRC government has also banned commercial and private flights to and from Bunia to prevent border spread. The WHO declared the outbreak as a public health emergency of international concern.
British scientists are working on developing an Ebola vaccine using the same technology as the AstraZeneca COVID-19 vaccine to fight a deadly sub-strain currently affecting the Democratic Republic of Congo (DRC) and its neighbors.
The vaccine, developed by the Oxford Vaccine Group (OVG), aims to address the rare species of Ebola causing the outbreak, for which there is currently no vaccine. It is expected to be ready for clinical trials within two to three months once clinical trials are approved. The WHO declared the outbreak as a public health emergency of international concern, and the DRC has suspended all flights to and from Bunia to control the spread of the virus
Ebola Vaccine Sub-Strain Democratic Republic Of Congo Astrazeneca COVID-19 Oxford Vaccine Group Chadox1 Bundibugyo Strain WHO Public Health Emergency Ban On Flights Border Spread
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
WHO chief says Ebola outbreak in Congo is 'spreading rapidly' and upgrades risk assessmentWorld Health Organization Director-General Tedros Adhanom Ghebreyesus said the U.N. health agency was revising upward to “very high” its assessment of the risk within Congo.
Read more »
WHO sounds alarm on 'deeply worrisome' Ebola spread in CongoThe United Nations announced Friday that it had released $60 million from its Central Emergency Response Fund to accelerate emergency response efforts.
Read more »
Developing an Ebola Vaccine to Tackle the Deadly Outbreak within MonthsA deadly outbreak of the Bundibugyo species of Ebola in the Democratic Republic of the Congo is being tackled by Oxford University scientists who are in the process of developing a vaccine using the same technology that underpinned its Covid-19 jab. While there is no proven jab for this species of Ebola, there is an Ebola vaccine for the Zaire species but not for the Bundibugyo strain.
Read more »
DR Congo’s neighbors impose Covid-style measures in push to limit Ebola’s spreadScreening tools and hygiene measures deployed during the Covid-19 pandemic are making a comeback, with Uganda temporarily suspending large cultural events as a precaution.
Read more »